Max Bayer has been promoted to senior reporter at Endpoints News.
“Max Bayer has been a star covering the drug industry’s relationship with the Trump administration, breaking scoop after scoop on drug pricing, vaccines, MAHA and the FDA,” said executive editor Drew Armstrong. “We’re promoting him to senior reporter as a long-overdue recognition of his talent and track record here at Endpoints.”
Bayer joined Endpoints in 2024. He had been a senior writer for Fierce Biotech covering the people and businesses developing new drugs.
Bayer previously worked at CBS News, where he was recently a reporter and researcher. He has also served as a news associate and associate producer. He has also interned at the Milwaukee Journal Sentinel, WisPolitics.com, and CBS News, among others. He has also contributed to USA Today.
Bayer graduated from the University of Wisconsin-Madison.
